Effect of Probiotic Supplementation on Autism Spectrum Disorder: A Review of Randomized Controlled Trials
Article Sidebar
Main Article Content
Abstract
Introduction: Autism spectrum disorder (ASD) is frequently associated with gut dysbiosis and gastrointestinal symptoms, prompting interest in therapeutic strategies targeting the microbiota, such as probiotic supplementation. This structured narrative review evaluates the effectiveness of probiotics in modulating core symptoms of ASD.
Methods: A structured narrative review was conducted following SANRA guidelines. Randomized controlled trials (RCTs) published between March 2015 and March 2025 were retrieved from the Epistemonikos Database of Trials. Study selection was performed independently by two reviewers, with discrepancies resolved by a third. Key data from eight selected RCTs were extracted and synthesized.
Results: Most included studies reported positive outcomes in domains such as gastrointestinal symptom improvement, reduction in repetitive behaviors, increased social interest, and gut microbiota modulation. Specific strains like Lactobacillus plantarum PS128 showed beneficial effects on neurobehavioral parameters. However, substantial heterogeneity was observed in strain types, doses, duration, and assessment tools.
Conclusions: Probiotic supplementation appears to be a promising dietary approach for managing ASD, especially in alleviating behavioral, social, and gastrointestinal symptoms. Nevertheless, effects are not universal, and further standardized RCTs are necessary to support robust clinical recommendations.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
OMS. Autismo [Internet]. 2023 [cited 2025 Apr 26]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/autism-spectrum-disorders
Alcalá GC, Ochoa Madrigal MG, Alcalá GC, Ochoa Madrigal MG. Trastorno del espectro autista (TEA). Revista de la Facultad de Medicina (México) [Internet]. 2022 Jan 10 [cited 2025 Apr 26];65(1):7–20. Available from: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026-17422022000100007&lng=es&nrm=iso&tlng=es
Nova R, Morales G, Ahumada D, Nova R, Morales G, Ahumada D. Factores nutricionales y alimentarios asociados al desarrollo y comportamiento del Espectro Autista: Un resumen de la evidencia. Revista chilena de nutrición [Internet]. 2022 Dec 1 [cited 2025 May 2];49(6):753–9. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75182022000700753&lng=es&nrm=iso&tlng=es
Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev [Internet]. 2019 Dec 26 [cited 2025 Jun 8];4(1):1–7. Available from: https://researchintegrityjournal.biomedcentral.com/articles/10.1186/s41073-019-0064-8
Billeci L, Callara AL, Guiducci L, Prosperi M, Morales MA, Calderoni S, et al. A randomized controlled trial into the effects of probiotics on electroencephalography in preschoolers with autism. Autism [Internet]. 2022 Jan 1 [cited 2025 Jun 8];27(1):117. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9806478/
Guidetti C, Salvini E, Viri M, Deidda F, Amoruso A, Visciglia A, et al. Randomized Double-Blind Crossover Study for Evaluating a Probiotic Mixture on Gastrointestinal and Behavioral Symptoms of Autistic Children. J Clin Med [Internet]. 2022 Sep 1 [cited 2025 Jun 8];11(18):5263. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9504504/
Kong XJ, Kang J, Liu K. Probiotic and intra-nasal oxytocin combination therapy on autonomic function and gut-brain axis signaling in young children and teens with autism spectrum disorder. J Psychiatr Res [Internet]. 2023 Oct 1 [cited 2025 Jun 8];166:1–9. Available from: https://www.sciencedirect.com/science/article/pii/S0022395623004004?via%3Dihub#sec4
Li YQ, Sun YH, Liang YP, Zhou F, Yang J, Jin SL. Chinese Journal of Contemporary Pediatrics [Internet]. 2021 Nov 9 [cited 2025 Jun 8];23(11):1103. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8580031/
Santocchi E, Guiducci L, Prosperi M, Calderoni S, Gaggini M, Apicella F, et al. Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial. Front Psychiatry [Internet]. 2020 Sep 25 [cited 2025 Jun 8];11:550593. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7546872/
Sherman HT, Liu K, Kwong K, Chan ST, Li AC, Kong XJ. Carbon monoxide (CO) correlates with symptom severity, autoimmunity, and responses to probiotics treatment in a cohort of children with autism spectrum disorder (ASD): a post-hoc analysis of a randomized controlled trial. BMC Psychiatry [Internet]. 2022 Dec 1 [cited 2025 Jun 8];22(1):536. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9358122/
Schmitt LM, Smith EG, Pedapati E V., Horn PS, Will M, Lamy M, et al. Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Sci Rep [Internet]. 2023 Dec 1 [cited 2025 Jun 8];13(1):1–12. Available from: https://www.nature.com/articles/s41598-023-30909-0
Narula Khanna H, Roy S, Shaikh A, Chhabra R, Uddin A. Impact of probiotic supplements on behavioural and gastrointestinal symptoms in children with autism spectrum disorder: A randomised controlled trial. BMJ Paediatr Open [Internet]. 2025 Mar 4 [cited 2025 Jun 9];9(1):e003045. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11881170/
He X, Liu W, Tang F, Chen X, Song G. Effects of Probiotics on Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis of Clinical Trials. Nutrients [Internet]. 2023 Mar 1 [cited 2025 Jun 10];15(6):1415. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10054498/